Chemoinformaics analysis of 1(7),2-P-Menthadien-4-Ol
Molecular Weight | 152.237 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
Exact Molecular Weight | 152.12 | nRing | 1 |
Solubility: LogS | -2.087 | nHRing | 0 |
Solubility: LogP | 2.254 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 1 | BPOL | 16.0513 |
QED | 0.611 |
Synth | 4.132 |
Natural Product Likeliness | 3.326 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.277 |
MDCK | 0.0000314 |
BBB | 0.995 |
PPB | 0.599313 |
VDSS | 1.525 |
FU | 0.431928 |
CYP1A2-inh | 0.179 |
CYP1A2-sub | 0.325 |
CYP2c19-inh | 0.108 |
CYP2c19-sub | 0.793 |
CYP2c9-inh | 0.059 |
CYP2c9-sub | 0.498 |
CYP2d6-inh | 0.1 |
CYP2d6-sub | 0.209 |
CYP3a4-inh | 0.085 |
CYP3a4-sub | 0.335 |
CL | 10.687 |
T12 | 0.633 |
hERG | 0.031 |
Ames | 0.086 |
ROA | 0.068 |
SkinSen | 0.929 |
Carcinogencity | 0.89 |
EI | 0.879 |
Respiratory | 0.768 |
NR-Aromatase | 0.049 |
Antiviral | No |
Prediction | 0.922663 |